BusinessCrown Bioscience Launches CrownSyn™, an Innovative Bioinformatics Solution that Simplifies the Characterization of Two-Drug Combination StudiesBy Nasdaq OMXJan 9, 2018, 1:00 PM UTC
BusinessTeneobio Announces a Strategic Alliance with TESARO to Develop the Next Generation of Immuno-Oncology, Multispecific AntibodiesBy Nasdaq OMXJan 8, 2018, 1:00 PM UTC
BusinessActinium Pharmaceuticals to Present at Biotech Showcase™ 2018 and Participate in Partnering SessionsBy Nasdaq OMXJan 3, 2018, 12:30 PM UTC
BusinessJAX Launches Tallwood Canine Cancer Research Initiative to Find the Most Effective Cancer Predictors and Treatments for Humans and DogsBy Nasdaq OMXDec 27, 2017, 9:51 PM UTC
BusinessTESARO Announces Availability of ZEJULA® (niraparib) for Women With Recurrent Ovarian Cancer in GermanyBy Nasdaq OMXDec 15, 2017, 9:00 AM UTC
BusinessActinium Pharmaceuticals Highlights Promising Data From its AWE Program Featuring a Potent Actinium-225 Labeled Daratumumab Labeled ARC or Antibody Radio-Conjugate Presented at ASH Annual MeetingBy Nasdaq OMXDec 12, 2017, 12:30 PM UTC
BusinessNew Study Shows Hospitals’ 340B Profit Margins Increasing; Growing Discounts Putting Upward Pressure on Drug PricesBy Nasdaq OMXDec 12, 2017, 12:00 PM UTC
